NATCO Pharma Limited (BOM:524816)
1,094.10
+4.00 (0.37%)
At close: Apr 28, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 195.96 billion as of April 28, 2026. Its market cap has increased by 30.79% in one year.
Market Cap
195.96B
Enterprise Value
166.57B
Revenue
45.63B
Ranking
n/a
PE Ratio
12.58
Stock Price
1,094.10
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 195.96B, an increase of 45,537.95%. That is a compound annual growth rate of 25.36%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 212.54B |
| Granules India | 170.76B |
| Rubicon Research | 154.65B |
| Jubilant Pharmova | 149.60B |
| Caplin Point Laboratories | 130.50B |
| J. B. Chemicals & Pharmaceuticals | 321.75B |
| CORONA Remedies | 99.90B |
| GlaxoSmithKline Pharmaceuticals | 418.95B |